Clinical Trial

Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for Pain Alleviation in Chronic Refractory Migraine.

Recruiting
View on ClinicalTrials.gov →
Summary
* PRF performed on the sphenopalatine ganglion level under ultrasound guidance. * Standard voltage PRF parameters: 45 V, 5 Hz frequency, 5 ms pulse width, 360 seconds duration, electrode temperature ≤42°C. * Supravoltage PRF parameters: Higher voltage than standard (e.g., 60-70 V), with same frequency, pulse width, and duration, maintaining temperature ≤42°C to avoid nerve damage.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-06-17
critical Recruitment opened 2026-06-04
Trial Details
NCT Number NCT07500558
Lead Sponsor Minia University
Conditions Chronic Migraine, Headache
Enrollment 100 participants
Start Date 2026-03-31
Primary Completion 2027-03-22 (estimated)
Study Completion 2027-04-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-16